Hamps Bio Limited , a prominent player in the biotech industry, has announced significant changes to its board composition. The company's shareholders have unanimously approved the appointment of Ms. Shivali Rajpurohit as a Non-Executive Independent Director.

Shareholder Approval

At the Extra Ordinary General Meeting held on November 24, 2025, Hamps Bio Limited's shareholders voted unanimously in favor of Ms. Rajpurohit's appointment. The resolution received 100% approval with 6,288,000 votes in favor and no votes against. Twelve members participated in the physical voting process, demonstrating strong support for this board addition.

New Independent Director Appointment

Ms. Shivali Rajpurohit brings a wealth of experience to her new role at Hamps Bio Limited. She is a qualified Company Secretary with a degree in law (LL.B) and specializes in corporate laws, secretarial compliance, including Companies Act, SEBI Regulations, Legal Documentation, Regulatory Filings, and Governance Framework. With over two years of experience handling legal and secretarial matters for both listed and unlisted entities, Ms. Rajpurohit is well-equipped to contribute to the company's governance and compliance efforts.

The appointment is for a five-year term, commencing from August 25, 2025. Ms. Rajpurohit is not related to any existing directors of Hamps Bio Limited and is not debarred from holding directorship positions by SEBI or any other authority.

Board Committee Reconstitution

Following Ms. Rajpurohit's appointment, Hamps Bio Limited has announced a significant reshuffle of its board committees:

Audit Committee

• Chairperson: Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
• Members:
  • Ms. Shivali Rajpurohit (Independent Non-Executive Director)
  • Mrs. Pallavi Herrik Shah (Non-Executive Director)

Nomination and Remuneration Committee

• Chairperson: Ms. Shivali Rajpurohit (Independent Non-Executive Director)
• Members:
  • Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
  • Mrs. Pallavi Herrik Shah (Non-Executive Director)

Stakeholders Relationship Committee

• Chairperson: Mrs. Pallavi Herrik Shah (Non-Executive Director)
• Members:
  • Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
  • Ms. Shivali Rajpurohit (Independent Non-Executive Director)

These changes in the board composition and committee structure are aimed at enhancing the company's corporate governance practices and ensuring compliance with regulatory requirements.

The appointment of Ms. Rajpurohit and the reconstitution of board committees reflect Hamps Bio Limited's commitment to maintaining a strong and diverse leadership team. These strategic moves are expected to bring fresh perspectives and strengthen the company's decision-making processes in the dynamic biotech industry.

Hamps Bio Limited has announced an Extraordinary General Meeting (EGM) scheduled for November 24, 2025, to address a significant corporate governance matter. The meeting, set to take place at 4:00 PM at the company's corporate office in Surat, Gujarat, will focus on the regularization of Ms. Shivali Rajpurohit's appointment as a Non-Executive Independent Director.

Key Details of the EGM

About the Directorial Appointment

Ms. Shivali Rajpurohit was initially appointed as an Additional Director on August 25, 2025. The EGM will consider her regularization as a Non-Executive Independent Director for a five-year term, from August 25, 2025, to August 24, 2030.

Director Profile

Ms. Rajpurohit brings expertise in corporate laws, secretarial compliance, and SEBI regulations. Her experience spans both listed and unlisted entities, making her well-suited for the role of an Independent Director in a publicly traded company.

Compliance and Governance

The company has stated that Ms. Rajpurohit has submitted a declaration of independence, and the Board believes she meets the criteria for appointment as an Independent Director under the Companies Act, 2013. This appointment aligns with Hamps Bio Limited's commitment to maintaining strong corporate governance practices.

Shareholder Participation

Shareholders are encouraged to attend the EGM or appoint proxies if unable to attend personally. The company has made provisions for electronic voting and has sent the EGM notice to shareholders whose email addresses are registered with the company or depository participants.

This EGM and the proposed appointment of Ms. Rajpurohit represent Hamps Bio Limited's ongoing efforts to strengthen its board composition and adhere to regulatory requirements for listed entities.